US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist
  • 2.900
  • +0.110+3.94%
Close Dec 20 16:00 ET
  • 2.900
  • 0.0000.00%
Post 20:01 ET
380.37MMarket Cap-1.41P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
209K
0
591K
0
0
0
0
0
0
0
Operating revenue
--209K
--0
--591K
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.79%54.44M
23.01%55.67M
22.23%48.93M
64.14%191.29M
40.99%54.54M
62.57%51.46M
72.05%45.26M
101.19%40.03M
37.96%116.54M
-35.60%38.69M
Selling and administrative expenses
34.38%14.1M
18.23%12.6M
21.91%11.16M
45.50%43.39M
35.94%13.08M
58.79%10.49M
44.71%10.66M
47.13%9.15M
114.16%29.82M
33.92%9.63M
-General and administrative expense
34.38%14.1M
18.23%12.6M
21.91%11.16M
45.50%43.39M
35.94%13.08M
58.79%10.49M
44.71%10.66M
47.13%9.15M
114.16%29.82M
33.92%9.63M
Research and development costs
-1.53%40.34M
24.49%43.07M
22.33%37.77M
70.54%147.91M
42.66%41.46M
63.56%40.97M
82.68%34.6M
125.78%30.88M
22.93%86.73M
-45.05%29.06M
Operating profit
-5.39%-54.23M
-23.01%-55.67M
-20.75%-48.34M
-64.14%-191.29M
-40.99%-54.54M
-62.57%-51.46M
-72.05%-45.26M
-101.19%-40.03M
-37.96%-116.54M
35.60%-38.69M
Net non-operating interest income expense
70.00%697K
-3.78%611K
410K
635K
Non-operating interest income
70.00%697K
-3.78%611K
----
----
----
--410K
--635K
----
----
----
Other net income (expense)
336.48%1.02M
-117.64%-400K
525.35%2.71M
-14.38%-7.12M
-1,021.33%-8.78M
-90.74%233K
165.08%2.27M
109.70%434K
92.35%-6.23M
46.15%-783K
Gain on sale of security
113.62%215K
-831.94%-1.93M
168.55%1.17M
70.69%-2.38M
137.16%635K
-188.26%-1.58M
107.06%263K
62.07%-1.7M
-1,978.77%-8.13M
-16.58%-1.71M
Special income (charges)
----
----
----
---13.5M
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
--13.5M
----
----
----
----
----
----
Other non- operating income (expenses)
-293.02%-83K
-4.88%39K
-27.49%1.55M
360.43%8.76M
832.61%8.64M
-94.09%43K
-82.77%41K
19,309.09%2.14M
102.35%1.9M
7,616.67%926K
Income before tax
-3.35%-52.52M
-30.95%-55.46M
-15.22%-45.63M
-61.61%-198.41M
-66.32%-65.64M
-74.40%-50.82M
-42.18%-42.35M
-62.48%-39.6M
25.98%-122.77M
35.85%-39.47M
Income tax
0
-532.26%-134K
166.34%134K
70.57%-279K
0
-150.94%-108K
107.01%31K
62.03%-202K
-95.06%-948K
-113.47%-186K
Net income
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
-72.77%-50.71M
-44.42%-42.39M
-65.26%-39.4M
26.33%-121.82M
37.56%-39.28M
Net income continuous Operations
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
-72.77%-50.71M
-44.42%-42.39M
-65.26%-39.4M
26.33%-121.82M
37.56%-39.28M
Minority interest income
Net income attributable to the parent company
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
-72.77%-50.71M
-44.42%-42.39M
-65.26%-39.4M
26.33%-121.82M
37.56%-39.28M
Preferred stock dividends
16.83%20.19M
-79.35%1.31M
Other preferred stock dividends
Net income attributable to common stockholders
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-39.52%-198.13M
-61.69%-65.64M
-41.99%-50.71M
-18.92%-42.39M
-31.04%-39.4M
22.87%-142.01M
41.40%-40.6M
Basic earnings per share
20.00%-0.44
2.13%-0.46
0.00%-0.44
47.97%-2.18
-28.57%-0.72
-45.29%-0.55
5.32%-0.47
-5.08%-0.44
-63.39%-4.19
41.96%-0.56
Diluted earnings per share
20.00%-0.44
2.13%-0.46
0.00%-0.44
47.97%-2.18
-28.57%-0.72
-45.29%-0.55
5.32%-0.47
-5.08%-0.44
-63.39%-4.19
41.96%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 209K0591K0000000
Operating revenue --209K--0--591K--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.79%54.44M23.01%55.67M22.23%48.93M64.14%191.29M40.99%54.54M62.57%51.46M72.05%45.26M101.19%40.03M37.96%116.54M-35.60%38.69M
Selling and administrative expenses 34.38%14.1M18.23%12.6M21.91%11.16M45.50%43.39M35.94%13.08M58.79%10.49M44.71%10.66M47.13%9.15M114.16%29.82M33.92%9.63M
-General and administrative expense 34.38%14.1M18.23%12.6M21.91%11.16M45.50%43.39M35.94%13.08M58.79%10.49M44.71%10.66M47.13%9.15M114.16%29.82M33.92%9.63M
Research and development costs -1.53%40.34M24.49%43.07M22.33%37.77M70.54%147.91M42.66%41.46M63.56%40.97M82.68%34.6M125.78%30.88M22.93%86.73M-45.05%29.06M
Operating profit -5.39%-54.23M-23.01%-55.67M-20.75%-48.34M-64.14%-191.29M-40.99%-54.54M-62.57%-51.46M-72.05%-45.26M-101.19%-40.03M-37.96%-116.54M35.60%-38.69M
Net non-operating interest income expense 70.00%697K-3.78%611K410K635K
Non-operating interest income 70.00%697K-3.78%611K--------------410K--635K------------
Other net income (expense) 336.48%1.02M-117.64%-400K525.35%2.71M-14.38%-7.12M-1,021.33%-8.78M-90.74%233K165.08%2.27M109.70%434K92.35%-6.23M46.15%-783K
Gain on sale of security 113.62%215K-831.94%-1.93M168.55%1.17M70.69%-2.38M137.16%635K-188.26%-1.58M107.06%263K62.07%-1.7M-1,978.77%-8.13M-16.58%-1.71M
Special income (charges) ---------------13.5M------------------0----
-Less:Other special charges --------------13.5M------------------------
Other non- operating income (expenses) -293.02%-83K-4.88%39K-27.49%1.55M360.43%8.76M832.61%8.64M-94.09%43K-82.77%41K19,309.09%2.14M102.35%1.9M7,616.67%926K
Income before tax -3.35%-52.52M-30.95%-55.46M-15.22%-45.63M-61.61%-198.41M-66.32%-65.64M-74.40%-50.82M-42.18%-42.35M-62.48%-39.6M25.98%-122.77M35.85%-39.47M
Income tax 0-532.26%-134K166.34%134K70.57%-279K0-150.94%-108K107.01%31K62.03%-202K-95.06%-948K-113.47%-186K
Net income -3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M-72.77%-50.71M-44.42%-42.39M-65.26%-39.4M26.33%-121.82M37.56%-39.28M
Net income continuous Operations -3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M-72.77%-50.71M-44.42%-42.39M-65.26%-39.4M26.33%-121.82M37.56%-39.28M
Minority interest income
Net income attributable to the parent company -3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M-72.77%-50.71M-44.42%-42.39M-65.26%-39.4M26.33%-121.82M37.56%-39.28M
Preferred stock dividends 16.83%20.19M-79.35%1.31M
Other preferred stock dividends
Net income attributable to common stockholders -3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-39.52%-198.13M-61.69%-65.64M-41.99%-50.71M-18.92%-42.39M-31.04%-39.4M22.87%-142.01M41.40%-40.6M
Basic earnings per share 20.00%-0.442.13%-0.460.00%-0.4447.97%-2.18-28.57%-0.72-45.29%-0.555.32%-0.47-5.08%-0.44-63.39%-4.1941.96%-0.56
Diluted earnings per share 20.00%-0.442.13%-0.460.00%-0.4447.97%-2.18-28.57%-0.72-45.29%-0.555.32%-0.47-5.08%-0.44-63.39%-4.1941.96%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data